FDA Removes Boxed Warnings on Menopausal Hormone Therapy

This course discusses the FDA’s recent removal of boxed warnings for certain menopausal hormone therapy products, exploring the rationale behind the change and its impact on patient care.

• The description claims that the FDA’s updated position on boxed warnings for menopausal hormone therapy may not accurately reflect the therapy’s risk-benefit profile for all patients.